DG(13 years), family-history hypertension(IA), dyslipidemia, CVD; MG(14 years), family-history IA, both Tanner IV.Different school conducts-integration (DG:restless-good, MG: good-problematic); ~7h/day of sedentary, MG is solitary, DG wishes to be more social, trains(~6hrs/week) and walks.No breakfast; junk food, or absent(MG); lunch and dinner alone or in family(MG); extra-snacks; soft-drink≥1/day. Both do nutritional mistakes.Abstract 1424 Table 1 T0 z-BMI W WtHR BP

No abstract

s disease. Nine patients were treated by thrombocyte transfusion, tranexamic acid, recombinant active factor VII and fibrin glue as a single or combined therapy in invasive procedures; none of them had a major bleeding complication. Conclusion Bleeding control of invasive procedures may be challenging in children with Glazmann thrombasthenia; local treatments, DDAVP, steroid and antifibrinolytics may be used with success.